Find Zaleplon manufacturers, exporters & distributors on PharmaCompass

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 9 USDMF, 3 EU WC, 4 NDC API, 5 Listed Suppliers, $ API Reference Price

14 API Suppliers
9 USDMF
3 EU WC
4 NDC API
5 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers, 22 FDA Orange Book, 6 Europe, 5 Listed Dossiers

33 FDF Dossiers
22 FDA Orange Book
6 Europe
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 5MG

drugProductComposition
CAPSULE;ORAL - 10MG
CAPSULE;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 8 DKSH, 4 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 5 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 26 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 17 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 29 Direct Compression, 22 Thickeners and Stabilizers, 17 Granulation, 16 Lubricants & Glidants, 15 Coating Systems & Additives, 15 Co-Processed Excipients, 12 Topical, 11 Controlled & Modified Release, 9 Disintegrants & Superdisintegrants, 8 Taste Masking, 8 Film Formers & Plasticizers, 8 Empty Capsules, 6 Solubilizers, 5 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 4 Parenteral, 3 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

8 NEWS #PharmaBuzz

media
8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 14 Finished Drug Prices

globalSalesInformation
1 US Medicaid Prescriptions
14 Finished Drug Prices

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP , 4 Others

otherSolutions
2 USP
4 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 1,067

MARKET PLACE

API

FDF

3INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

4,765,184

Annual Reports (USD Million)

Finished Drug Prices

160 RELATED EXCIPIENT COMPANIES

257EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 151319-34-5, Sonata, Cl-284846, Skp-1041, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide, Zal-846

Molecular Formula

C₁₇H₁₅N₅O

Molecular Weight

305.33 g/mol

InChI Key

HUNXMJYCHXQEGX-UHFFFAOYSA-N

FDA UNII

S62U433RMH

Zaleplon is a nonbenzodiazepine from the pyrazolopyrimidine class with hypnotic, sedative, anxiolytic, and muscle relaxant properties. Zaleplon interacts with the gamma-aminobutyric acid (GABA) -A receptor, thereby affecting the chloride channel ionophore complex and potentiating the inhibitory effects of GABA. In addition, zaleplon binds selectively to the brain omega-1 receptor situated on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.

Zaleplon is a gamma-Aminobutyric Acid A Receptor Agonist. The mechanism of action of zaleplon is as a GABA A Agonist. The physiologic effect of zaleplon is by means of Central Nervous System Depression.

1 2D Structure

Zaleplon

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide

2.1.2 InChI

InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3

2.1.3 InChI Key

HUNXMJYCHXQEGX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C

2.2 Other Identifiers

2.2.1 UNII

S62U433RMH

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3'-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-n-ethylacetanilide

2. Cl 284,846

3. Cl 284846

4. Cl-284846

5. Cl284,846

6. L 846

7. L-846

8. N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n-ethylacetamide

9. Skp-1041

10. Sonata

11. Starnoc

12. Zelepion

2.3.2 Depositor-Supplied Synonyms

1. 151319-34-5

2. Sonata

3. Cl-284846

4. Skp-1041

5. N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide

6. Zal-846

7. Cl 284,846

8. Ljc 10846

9. L846

10. Cl 284846

11. Ljc-10846

12. L-846

13. Dea No. 2781

14. Zaleplon Civ

15. 3'-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)-n-ethylacetanilide

16. N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n-ethylacetamide

17. S62u433rmh

18. Chebi:10102

19. N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-n-ethylacetamide

20. Ncgc00160525-01

21. Dsstox_cid_3748

22. Dsstox_rid_77183

23. Dsstox_gsid_23748

24. Zal 846

25. N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-n-ethylacetamide

26. Staccato-zaleplon

27. Smr000238180

28. Sonata (tn)

29. Cas-151319-34-5

30. Unii-s62u433rmh

31. Zaleplon Ap

32. Zaleplon [usan:usp:inn:ban]

33. 3'-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-n-ethylacetanilide

34. Az-007

35. Zaleplon [usan]

36. Zaleplon [inn]

37. Zaleplon [jan]

38. Zaleplon [mi]

39. Zaleplon [vandf]

40. Zaleplon [mart.]

41. Zaleplon [who-dd]

42. Acetamide, N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n-ethyl-

43. Zaleplon (jan/usp/inn)

44. Chembl1521

45. Zaleplon [ema Epar]

46. Schembl29118

47. Mls000759451

48. Mls001424238

49. Bidd:gt0046

50. Zaleplon [orange Book]

51. Zaleplon Civ [usp-rs]

52. Gtpl4345

53. Zinc6300

54. Dtxsid5023748

55. Zaleplon [usp Monograph]

56. Bdbm86521

57. Zaleplon 1.0 Mg/ml In Methanol

58. Hms2052j11

59. Hms3394j11

60. Hms3713h08

61. Act04427

62. Bcp21340

63. Cas_5719

64. Nsc_5719

65. Tox21_111872

66. N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide

67. Zaleplon, >=98% (hplc), Solid

68. Acetamide, N-(3-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)phenyl)-n-ethyl-

69. Akos000280863

70. Tox21_111872_1

71. Ac-2082

72. Ccg-101187

73. Db00962

74. Nc00437

75. Ss-4571

76. Ncgc00160525-02

77. Hy-14265

78. Db-015068

79. A12993

80. C07484

81. D00530

82. Ab00640003_03

83. 319z345

84. A809159

85. Q145052

86. Sr-01000759426

87. Sr-01000759426-3

88. Zaleplon, United States Pharmacopeia (usp) Reference Standard

89. N-[3-(cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide

90. 3'-(3-cyanopyrazolo(1,5-.alpha.)pyrimidin-7-yl)-n-ethylacetanilide

91. N-[3-(3-cyanopyrazolo-[1,5-a]-pyrimidin-7-yl)-phenyl]-n-ethyl Acetamide

92. Acetamide, N-(3-(3-cyanopyrazolo(1,5-.alpha.)pyrimidin-7-yl)phenyl)-n-ethyl-

93. Zaleplon Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material

94. 1007130-22-4

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₁₅N₅O
Molecular Weight	305.33 g/mol
XLogP3	1
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	3
Exact Mass	305.12766012 g/mol
Monoisotopic Mass	305.12766012 g/mol
Topological Polar Surface Area	74.3 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	487
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 4
Drug Name	Sonata
PubMed Health	Zaleplon (By mouth)
Drug Classes	Nonbarbiturate Hypnotic
Drug Label	Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. The chemical name of zaleplon is N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide. Its empirical formula is C17H15N5O, and its molecular weight is 305.34....
Active Ingredient	Zaleplon
Dosage Form	Capsule
Route	Oral
Strength	5mg; 10mg
Market Status	Prescription
Company	Pfizer

2 of 4
Drug Name	Zaleplon
PubMed Health	Zaleplon (By mouth)
Drug Classes	Nonbarbiturate Hypnotic
Drug Label	Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. The chemical name of zaleplon is N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide. Its empirical formula is C17H15N5O, and its molecular weight is 305.34....
Active Ingredient	Zaleplon
Dosage Form	Capsule
Route	Oral
Strength	5mg; 10mg
Market Status	Prescription
Company	Upsher Smith; Unichem; Aurobindo Pharma; Cipla; Hikma Pharms; Roxane; Teva Pharms; Orchid Hlthcare; Mylan

3 of 4
Drug Name	Sonata
PubMed Health	Zaleplon (By mouth)
Drug Classes	Nonbarbiturate Hypnotic
Drug Label	Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. The chemical name of zaleplon is N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide. Its empirical formula is C17H15N5O, and its molecular weight is 305.34....
Active Ingredient	Zaleplon
Dosage Form	Capsule
Route	Oral
Strength	5mg; 10mg
Market Status	Prescription
Company	Pfizer

4 of 4
Drug Name	Zaleplon
PubMed Health	Zaleplon (By mouth)
Drug Classes	Nonbarbiturate Hypnotic
Drug Label	Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. The chemical name of zaleplon is N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide. Its empirical formula is C17H15N5O, and its molecular weight is 305.34....
Active Ingredient	Zaleplon
Dosage Form	Capsule
Route	Oral
Strength	5mg; 10mg
Market Status	Prescription
Company	Upsher Smith; Unichem; Aurobindo Pharma; Cipla; Hikma Pharms; Roxane; Teva Pharms; Orchid Hlthcare; Mylan

4.2 Drug Indication

For the treatment of short-term treatment of insomnia in adults.

FDA Label

Sonata is indicated for the treatment of patients with insomnia who have difficulty falling asleep. It is indicated only when the disorder is severe, disabling or subjecting the individual to extreme distress.

5 Pharmacology and Biochemistry

5.1 Pharmacology

Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABA_BZ) receptor complex. Subunit modulation of the GABA_BZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zaleplon also binds selectively to the CNS GABA_A-receptor chloride ionophore complex at benzodiazepine(BZ) omega-1 (BZ1, 1) receptors.

5.2 MeSH Pharmacological Classification

Anticonvulsants

Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)

Hypnotics and Sedatives

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)

GABA Modulators

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)

5.3 FDA Pharmacological Classification

5.3.1 Active Moiety

ZALEPLON

5.3.2 FDA UNII

S62U433RMH

5.3.3 Pharmacological Classes

GABA A Agonists [MoA]; gamma-Aminobutyric Acid A Receptor Agonist [EPC]; Central Nervous System Depression [PE]

5.4 ATC Code

N05CF03

N - Nervous system

N05 - Psycholeptics

N05C - Hypnotics and sedatives

N05CF - Benzodiazepine related drugs

N05CF03 - Zaleplon

5.5 Absorption, Distribution and Excretion

Absorption

Absorption Zaleplon is rapidly and almost completely absorbed following oral administration.

Route of Elimination

Zaleplon is metabolized primarily by the liver and undergoes significant presystemic metabolism. After oral administration, zaleplon is extensively metabolized, with less than 1% of the dose excreted unchanged in urine. Renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.

Volume of Distribution

1.4 L/kg

Clearance

1 L/h/kg

5.6 Metabolism/Metabolites

Zaleplon is primarily metabolized by aldehyde oxidase.

Zaleplon has known human metabolites that include Dementhylazed-zaleplon.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

5.7 Biological Half-Life

Approximately 1 hour

5.8 Mechanism of Action

Zaleplon exerts its action through subunit modulation of the GABA_BZ receptor chloride channel macromolecular complex. Zaleplon also binds selectively to the brain omega-1 receptor located on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.

API SUPPLIERS

01

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPhI WW Frankfurt

Booth #6.1A32

TAPI offers customized CDMO Solutions for API development and manufacturing services.

Contact Supplier

Israel

Virtual Booth

Digital Content

USDMF

Click Us!

CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Product Web Link

Corporate PDF

02

Orchid Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

03

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

04

Centaur Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

05

Apotex Pharmachem

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

06

Zydus Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

07

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

08

Gador SA

Argentina

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

09

Amino Chemicals

Malta

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

10

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"ZALEPLON","year":"2021","qtr":"Q1","strtotime":1611253800,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR EDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S.","customerCountry":"KOREA, REPUBLIC OF","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1460.5","totalValueFC":"1478.7","currency":"USD","unitRateINR":108150,"date":"22-Jan-2021","totalValueINR":"108150","totalValueInUsd":"1478.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8091618","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"ZALEPLON","year":"2021","qtr":"Q1","strtotime":1611253800,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR EDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S.","customerCountry":"KOREA, REPUBLIC OF","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"1460.5","totalValueFC":"7393.7","currency":"USD","unitRateINR":108150,"date":"22-Jan-2021","totalValueINR":"540750","totalValueInUsd":"7393.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8091608","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1631039400,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"M\/S.","customerCountry":"TAIWAN","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"1398","totalValueFC":"8211.4","currency":"USD","unitRateINR":100666.66666666667,"date":"08-Sep-2021","totalValueINR":"604000","totalValueInUsd":"8211.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4457603","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1650565800,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"M\/S.","customerCountry":"KOREA, REPUBLIC OF","quantity":"2.10","actualQuantity":"2.1","unit":"KGS","unitRateFc":"1500","totalValueFC":"3127.9","currency":"USD","unitRateINR":112380.95238095238,"date":"22-Apr-2022","totalValueINR":"236000","totalValueInUsd":"3127.9","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9867887","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659724200,"product":"ZALEPLON USP 41, BATCH NO.014005062022","address":"SHOP NO. D-4, NEELKANTH BUSINESS,P ARK CO-OP PREMISES SOCIETY LTD.","city":"NATHANI ROAD VIDHYA VIHAR WEST,MAHA","supplier":"PRECISE CHEMIPHARMA P LTD","supplierCountry":"INDIA","foreign_port":"SANAA","customer":"SHIBA PHARMACEUTICALS & ","customerCountry":"YEMEN","quantity":"60.00","actualQuantity":"60","unit":"KGS","unitRateFc":"590","totalValueFC":"32877.9","currency":"EUR","unitRateINR":43600,"date":"06-Aug-2022","totalValueINR":"2616000","totalValueInUsd":"32877.9","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"3346119","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"YEMEN, DEMOCRATIC","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"SHOP NO. D-4, NEELKANTH BUSINESS,P ARK CO-OP PREMISES SOCIETY LTD., NATHANI ROAD VIDHYA VIHAR WEST,MAHA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660761000,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"WARSAW","customer":"M\/S.","customerCountry":"POLAND","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"1250","totalValueFC":"61671.2","currency":"USD","unitRateINR":98140,"date":"18-Aug-2022","totalValueINR":"4907000","totalValueInUsd":"61671.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3560859","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692642600,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGR","address":"CENTAUR HOUSE SHANTI NAGARVAKOL A SANTACRUZ - EAST","city":"MUMBAI","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SEOUL","customer":"Z TO ORDER AND NA","customerCountry":"KOREA, REPUBLIC OF","quantity":"165.00","actualQuantity":"165","unit":"KGS","unitRateFc":"1300","totalValueFC":"212786.8","currency":"USD","unitRateINR":106827.11503030303,"date":"22-Aug-2023","totalValueINR":"17626473.98","totalValueInUsd":"212786.8","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE SHANTI NAGARVAKOL A SANTACRUZ - EAST, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720117800,"product":"ZALEPLON USP [ACTIVE PHARMACEUTICAL INGREDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MONTREAL, QC","customer":"TO THE ORDER OF","customerCountry":"CANADA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2500","totalValueFC":"2285.7","currency":"USD","unitRateINR":191064,"date":"05-Jul-2024","totalValueINR":"191064","totalValueInUsd":"2285.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2206121","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726857000,"product":"PHARMACEUTICAL RAW MATERIAL\/BULK DRUGS-ZALEPLON USP","address":"309 HARIKRUPA TOWER NR.OLD-","city":"AHMEDABAD","supplier":"JAI RADHE SALES","supplierCountry":"INDIA","foreign_port":"TEGUCIGALPA","customer":"TO THE ORDER OF","customerCountry":"HONDURAS","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"838","totalValueFC":"712.3","currency":"USD","unitRateINR":59688,"date":"21-Sep-2024","totalValueINR":"59688","totalValueInUsd":"712.3","indian_port":"Ahmedabad Air","hs_no":"29242990","bill_no":"4212070","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"HONDURAS","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"309 HARIKRUPA TOWER NR.OLD-, AHMEDABAD","customerAddress":""}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

INTERMEDIATES SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 10MG

USFDA APPLICATION NUMBER - 20859

DOSAGE - CAPSULE;ORAL - 5MG

USFDA APPLICATION NUMBER - 20859

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Direct Compression

Thickeners and Stabilizers

Granulation

Lubricants & Glidants

Coating Systems & Additives

Co-Processed Excipients

Topical

Controlled & Modified Release

Disintegrants & Superdisintegrants

Taste Masking

Film Formers & Plasticizers

Empty Capsules

Solubilizers

Chewable & Orodispersible Aids

Emulsifying Agents

Parenteral

Coloring Agents

Surfactant & Foaming Agents

Rheology Modifiers

API Stability Enhancers

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Post Enquiry

Market Place

Find Zaleplon manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers

9 USDMF

3 EU WC

4 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers

22 FDA Orange Book

6 Europe

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG

CAPSULE;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

2 Seqens

8 DKSH

4 Faran Shimi Pharmaceutical

10 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

3 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

18 BASF

5 DFE Pharma

2 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

26 Kerry

3 Lonza Capsugel

12 Microlex e.U

2 Nomisma Healthcare

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qualicaps

17 Roquette

2 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders

29 Direct Compression

22 Thickeners and Stabilizers

17 Granulation

16 Lubricants & Glidants

15 Coating Systems & Additives

15 Co-Processed Excipients

12 Topical

11 Controlled & Modified Release

9 Disintegrants & Superdisintegrants

8 Taste Masking

8 Film Formers & Plasticizers

8 Empty Capsules

6 Solubilizers

5 Chewable & Orodispersible Aids

4 Emulsifying Agents

4 Parenteral

3 Coloring Agents

1 Surfactant & Foaming Agents

1 Rheology Modifiers

1 API Stability Enhancers

DIGITAL CONTENT

8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

14 Finished Drug Prices

PATENTS & EXCLUSIVITIES